Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

Share Price is delayed by 15 minutes
Get Live Data
285.20    0.20 (0.07%)
Bid:
284.70
Ask:
284.90
Spread: 0.20 (0.07%)
Market Cap: £15.63b
LGEN Live PriceLast checked at - London Stock Exchange

Intraday Legal & General Share Chart

Director/PDMR Shareholding

20 Jun 2024 18:15

RNS Number : 2892T
Legal & General Group Plc
20 June 2024
Β 

Β 

​

​

Legal & General Group Plc

Β 

Β 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

Β 

The following notification made under article 19 of the UK Market Abuse Regulation ("UK MAR") relates to the award of restricted shares on 18 June 2024. On 19 June 2024, Legal & General Group Plc (the "Company") received notification that on 18 June 2024 the PDMRs named below had been awarded restricted shares at a price of Β£2.2533 per ordinary share under the terms of the Share Bonus Plan ("SBP"). All SBP awards vest on 8 April 2027.

Β 

Β 

Name

Director/ PDMR

Number of SBP Restricted Shares awarded on 18 June 2024 at a price of Β£2.2533

Laura Mason

PDMR

167,746

Andrew Kail

PDMR

167,746

Β 

Β 

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Β 1. Laura Mason

Β 2. Andrew Kail

Β 

2

Reason for the notification

a)

Position/status

1. Chief Executive Officer, Private Markets/PDMR

Β 

2. Chief Executive Officer, Legal & General Retirement Institutional/PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Legal & General Group Plc

b)

LEI

213800JH9QQWHLO99821

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of Β£0.025 each, with voting rights attached

Β GB0005603997

b)

Nature of transaction

SBP restricted shares award for the PDMRs listed in 1a above

Β 

Β 

c)

Β 

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

1. Β£2.2533

1. 167,746

2. Β£2.2533

2. 167,746

d)

Aggregated information

- Aggregated volume

- Price

Β N/A (Single Transaction)

e)

Date of the transaction

18 June 2024

f)

Place of the transaction

London Stock Exchange, XLON

Β 

Β 

Β 

Β 

Β 

20 June 2024

Β 

Leanne Cornish

Head of Group Secretariat

Legal & General Group Plc

Β 

Tel: 020 3124 4111

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHQBLFLZQLLBBF
Date   Source Headline
16th Mar 20266:15 pmRNSDirectorate change
13th Mar 20266:15 pmRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSCommencement of Share Buyback
11th Mar 20267:00 amRNSL&G Full Year Results 2025
11th Mar 20267:00 amRNSL&G Full Year Results 2025
3rd Mar 20266:15 pmRNSDirector/PDMR Shareholding
2nd Mar 20266:15 pmRNSDirector/PDMR Shareholding
2nd Mar 20266:15 pmRNSDirector/PDMR Shareholding
2nd Mar 20266:15 pmRNSTotal Voting Rights
3rd Feb 20266:15 pmRNSDirector/PDMR Shareholding
2nd Feb 20266:15 pmRNSTotal Voting Rights
2nd Feb 20266:15 pmRNSDirector/PDMR Shareholding
2nd Feb 20266:15 pmRNSDirector/PDMR Shareholding
2nd Feb 20261:53 pmRNSL&G completes transaction with Meiji Yasuda
7th Jan 20266:15 pmRNSDirector/PDMR Shareholding
5th Jan 20266:15 pmRNSDirector/PDMR Shareholding
2nd Jan 20266:15 pmRNSDirector/PDMR Shareholding
2nd Jan 20266:15 pmRNSDirector/PDMR Shareholding
2nd Jan 20266:15 pmRNSBlock listing Interim Review
2nd Jan 20266:15 pmRNSDirector/PDMR Shareholding
2nd Jan 20266:15 pmRNSTotal Voting Rights
2nd Jan 20265:00 pmRNSRedemption of Debt
19th Dec 20259:00 amRNSDirector Declaration
19th Dec 20259:00 amRNSDirector Declaration
2nd Dec 20256:15 pmRNSDirector/PDMR Shareholding
1st Dec 20256:15 pmRNSDirector/PDMR Shareholding
1st Dec 20256:15 pmRNSDirector/PDMR Shareholding
1st Dec 20256:15 pmRNSTotal Voting Rights
18th Nov 20256:15 pmRNSDirector/PDMR Shareholding
4th Nov 20256:15 pmRNSDirector/PDMR Shareholding
3rd Nov 20256:15 pmRNSDirector/PDMR Shareholding
3rd Nov 20256:15 pmRNSDirector/PDMR Shareholding
3rd Nov 20256:15 pmRNSTotal Voting Rights
23rd Oct 20257:00 amRNSL&G Deep Dive: Retail
13th Oct 20257:00 amRNSScott Wheway appointed Legal & General Chair
2nd Oct 20256:15 pmRNSDirector/PDMR Shareholding
1st Oct 20256:15 pmRNSDirector/PDMR Shareholding
1st Oct 20256:15 pmRNSDirector/PDMR Shareholding
1st Oct 20256:15 pmRNSDirector/PDMR Shareholding
1st Oct 20256:15 pmRNSTotal Voting Rights
30th Sep 20257:00 amRNSAndrew Kail appointed as L&G's Group CFO
29th Sep 20256:15 pmRNSDirector/PDMR Shareholding
29th Sep 20256:15 pmRNSDirector/PDMR Shareholding
26th Sep 20256:15 pmRNSDirector/PDMR Shareholding
8th Sep 202511:00 amRNSTender Offer - Final Results
3rd Sep 20257:00 amRNSCompletion of £500m Share Buyback Programme
2nd Sep 20256:15 pmRNSTransaction in Own Shares
2nd Sep 20256:15 pmRNSDirector/PDMR Shareholding
2nd Sep 202511:45 amRNSPublication of Final Terms
1st Sep 20256:15 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.